TPTX News
Archived Headlines
- US IPO Week Ahead: Pinterest and Zoom headline year's busiest week with 8 IPOs 04/12/19
- Cancer biotech Turning Point Therapeutics sets terms for $125 million IPO 04/08/19
- US IPO Weekly Recap: A pair of jeans and a decacorn 03/23/19
- Early stage cancer biotech Turning Point Therapeutics files for a $100 million IPO 03/21/19
US IPO Weekly Recap: All IPOs up or flat in an 8-IPO week led by Pinterest and Zoom
Despite losing a day, this has been the busiest week of the year for IPOs with 8 IPOs raising $8.9 billion led by Zoom Video (ZM), which popped 72% on its first day of trading after raising $751 million in an IPO that priced above its...read more
Turning Point Therapeutics prices IPO at $18, the high end of the range
Turning Point Therapeutics, an early stage biotech developing tyrosine kinase inhibitors for treating cancer, raised $167 million by offering 9.3 million shares at $18, the high end of the range of $16 to $18. Turning Point Therapeutics plans to list on...read more
Investor Interest in Biotechs Continues
Interest in novel therapeutics continues, evidenced by the announcement by oncology biotech Turning Point (TPTX) that it increased the number of shares by 20% to 8.8 million, giving it a market cap of $547 million and $237 million in cash. Turning...read more
Turning Point Therapeutics increases proposed IPO offer size
Turning Point Therapeutics, an early stage biotech developing tyrosine kinase inhibitors for treating cancer, raised the proposed offer size for its upcoming IPO on Tuesday. The San Diego, CA-based company now plans to raise $150 million by offering 8.8...read more